KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $199,000 | +74.6% | 1,104 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $114,000 | +31.0% | 1,104 | -0.5% | 0.00% | 0.0% |
| Q1 2017 | $87,000 | +8600.0% | 1,110 | +6066.7% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 18 | +157.1% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 7 | +40.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 5 | -50.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 10 | +150.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|